论文部分内容阅读
我院1981年12月～1986年12月加用左旋咪唑(LMS)辅助肺结核化疗药物治疗84例痰菌阳性病人(另设对照组84例),报告如下。临床资料本组84例,对照组84例,合计168例(经随机化选择原则)。男88例,女80例。年龄最小16岁,最大60岁。初治患者70例,复治98例。全部病例均经X线透视或/和摄片诊断为肺结核,临床检查无肺外结核,痰菌检查均为阳性。 1.分组方法:70例初治患者为甲组,并随机分为LMS组和对照组各35例。本组化疗方案:INH 0.3+SM 0.75+EMB 0.75/日,连
Our hospital from December 1981 to December 1986 plus levamisole (LMS) adjuvant chemotherapy for tuberculosis 84 cases of sputum positive patients (another 84 cases of control group), the report is as follows. Clinical data 84 cases in this group, the control group of 84 cases, a total of 168 cases (by random selection principle). There were 88 males and 80 females. Youngest 16 years old, maximum 60 years old. The initial treatment of 70 patients, retreatment 98 cases. All cases were diagnosed as pulmonary tuberculosis by X-ray or / and radiography, no pulmonary tuberculosis was found in clinical examination, and sputum examination was positive. 1. Method of grouping: 70 cases of newly diagnosed patients were Group A and were randomly divided into LMS group and control group of 35 cases. The group chemotherapy: INH 0.3 + SM 0.75 + EMB 0.75 / day, even